CoChat

MAPK phosphatase‐1 represents a novel anti‐inflammatory target of glucocorticoids in the human endothelium

Open access
Fürst, Robert, Schroeder, Timm, Eilken, Hanna M., Bubik, Martin F., Kiemer, Alexandra K., Zahler, Stefan, Vollmar, Angelika M. · 2007 · The FASEB Journal
Cited by 95

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Glucocorticoids are well‐established anti‐inflammatory drugs thought to mainly act by inhibition of proinflammatory transcription factors like NFKB. In recent years, however, transcription factor‐independent mechanisms of glucocorticoid action have been proposed, namely the influence on MAPK pathways. Here we identify MAPK phosphatase‐1 (MKP‐1) as a pivotal mediator of the anti‐inflammatory action of glucocorticoids in the human endothelium. We applied dexamethasone (Dex) to TNF‐a‐activated human endothelial cells and used the adhesion molecule E‐selectin as inflammatory read‐out parameter. Dex is known to reduce the expression of E‐selectin, which is largely regulated by NF‐κB. Here, we communicate that Dex at low concentrations (1–100 nM) markedly attenuates E‐selectin expression without affecting NF‐κB. Importantly, Dex is able to increase the expression of MKP‐1, which causes an inactivation of TNF‐α‐induced p38 MAPK and mediates inhibition of E‐selectin expression. In endothelial MKP‐1 ‐/‐ cells differentiated from MKP‐1 ‐/‐ embryonic stem cells and in MKP‐1‐silenced human endothelial cells, Dex did not inhibit TNF‐α‐evoked E‐selectin expression. Thus, our findings introduce MKP‐1 as a novel and crucial mediator of the anti‐inflammatory action of glucocorticoids at low concentrations in the human endothelium and highlight MKP‐1 as an important and promising anti‐inflammatory drug target. Fürst, R., Schroeder, T., Eilken, H. M., Bubik, M. F., Kiemer, A. K., Stefan Zahler, S., Vollmar, A. M. MAPK phosphatase‐1 represents a novel anti‐inflammatory target of glucocorticoids in the human endothelium FASEB J. 21, 74–80 (2007)

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1096/fj.06-6752com

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 95

Metadata

Authors
Fürst, R., Schroeder, T., Eilken, H. M., Bubik, M. F., Kiemer, A. K., Zahler, S., & Vollmar, A. M.
Venue
The FASEB Journal
Publisher
Wiley
Published
2006-11-10
Volume
21
Issue
1
Pages
74-80
ISSN
  • 0892-6638 (ISSN-L)
  • 1530-6860
OpenAlex
W1972068895
Cited by
95
References
4
FWCI
3.56
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: MAPK phosphatase‐1 represents a novel anti‐inflammatory target of glucocorticoids in the human endothelium. https://app.cochat.ai/papers/10.1096/fj.06-6752com
The paper
Fürst, R., Schroeder, T., Eilken, H. M., Bubik, M. F., Kiemer, A. K., Zahler, S., & Vollmar, A. M. (2007). MAPK phosphatase‐1 represents a novel anti‐inflammatory target of glucocorticoids in the human endothelium. The FASEB Journal. https://doi.org/10.1096/fj.06-6752com

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.